pembrolizumab,INT230-6
merck,intensity therapeutics
['keytruda', 'intensity therapeutics']
at the same time int230-6 data alone and combined with keytruda was just discussed and presented at #asco22 in live podium discussion session. dr. jacob thomas from usc was on the podium to answer questions.
Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to create safer and more efficacious cancer therapies.